Promptly Health Expands Data Network to Include 70 Million in Brazil

Portuguese data firm Promptly Health has announced its entry into the Brazilian market, integrating clinical data from over 16 million beneficiaries through a partnership with Hapvida NotreDame Intermédica, one of Latin America's largest healthcare groups. This expansion significantly broadens Promptly Health's database, now covering more than 70 million people across Europe and Brazil, enabling a more diverse health-data infrastructure for research and clinical evidence generation.

The integration allows for secure sharing of clinical knowledge among hospitals and health systems without compromising sensitive patient data. This innovative federated data platform ensures that healthcare institutions retain control over their generated data while providing researchers and authorized organizations access to invaluable clinical information. Pedro Ramos, CEO of Promptly Health, emphasized the importance of this development, noting that Brazil's rich clinical data landscape has largely remained untapped by the global research community.

As the demand for comprehensive health data grows, the collaboration aims to create one of the world's most extensive federated clinical data ecosystems. This initiative not only enhances research capabilities but also aligns with global trends toward data-driven healthcare solutions, which are increasingly vital in addressing public health challenges.

The move marks a significant step for Promptly Health, positioning it to leverage Brazil's vast clinical data resources, which are crucial for advancing healthcare research and improving patient outcomes. The partnership is expected to facilitate groundbreaking studies and innovations in the healthcare sector, benefiting both local and international research initiatives.

Market Impact

This expansion into Brazil may lead to increased interest in healthcare technology stocks and data analytics firms, as investors recognize the potential for enhanced research capabilities and improved healthcare outcomes. The integration of such a large dataset could also influence regulatory discussions around data privacy and usage in healthcare.

Investors will monitor how this development impacts healthcare research and the broader implications for data-sharing practices in the industry.

Share: